Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pheochromocytoma.

William M Manger1, Ray W Gifford

  • 1Department of Medicine, National Hypertension Association, 324 East 30th Street, New York, NY 10016, USA.

Journal of Clinical Hypertension (Greenwich, Conn.)
|February 1, 2002
PubMed
Summary

Pheochromocytoma, a rare tumor causing excess catecholamines, is lethal if untreated. Early diagnosis using plasma/urinary metanephrines and imaging, followed by surgery, offers a high success rate.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Obesity prevention in young schoolchildren: results of a pilot study.

The Journal of school health·2012
Same author

Renal functional, not morphological, abnormalities account for salt sensitivity in Dahl rats.

Journal of hypertension·2009
Same author

Adverse drug reactions in patients with phaeochromocytoma: incidence, prevention and management.

Drug safety·2007
Same author

An overview of pheochromocytoma: history, current concepts, vagaries, and diagnostic challenges.

Annals of the New York Academy of Sciences·2006
Same author

The vagaries of pheochromocytomas.

American journal of hypertension·2005
Same author

Pheochromocytoma: diagnosis and management update.

Current hypertension reports·2004

Area of Science:

  • Endocrinology
  • Oncology
  • Nephrology

Background:

  • Pheochromocytoma is a rare, catecholamine-secreting tumor with potentially lethal consequences if not diagnosed and treated.
  • Clinical manifestations, primarily hypertension, mimic other conditions, leading to diagnostic challenges.
  • Excess circulating catecholamines cause characteristic symptoms like hypertension, headaches, sweating, and palpitations.

Purpose of the Study:

  • To review diagnostic and treatment strategies for pheochromocytoma.
  • To highlight the importance of early and accurate diagnosis for patient outcomes.
  • To discuss the role of biochemical and imaging tests in pheochromocytoma management.

Main Methods:

  • Review of diagnostic tests including plasma free metanephrines, fractionated urinary metanephrines, clonidine suppression test, MRI, and 131I-MIBG scintigraphy.
  • Evaluation of surgical approaches (laparoscopic vs. open) and adjuvant therapies for malignant pheochromocytoma.
  • Analysis of diagnostic sensitivity and specificity of various methods.

Main Results:

  • Plasma free metanephrines and fractionated urinary metanephrines demonstrate high sensitivity (~100%) for pheochromocytoma diagnosis.
  • MRI is more sensitive than CT for tumor localization; 131I-MIBG uptake provides specificity.
  • Surgical resection is successful in 90% of cases; 10% of tumors are malignant, requiring multimodal treatment.

Conclusions:

  • Accurate diagnosis of pheochromocytoma relies on sensitive biochemical tests and specific imaging modalities.
  • Timely surgical intervention is crucial for curative treatment, with minimally invasive options for smaller tumors.
  • Malignant pheochromocytomas necessitate a comprehensive treatment strategy including surgery, chemotherapy, and radiation therapy.

Related Experiment Videos